English

NxStage Medical, Inc.

EDGAR

NXTM Quarterly report (10-Q) · filed 2018-11-07

177 filing records in this dataset, filed from 2005-12-01 to 2018-11-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

108 million USD

2018 Q3 · USD

Exact inputs and evidence

Revenue: 108122000 USD Source

Operating margin

1.17%

2018 Q3 · %

Exact inputs and evidence

Operating Income: 1262000 USD Source
Revenue: 108122000 USD Source

Operating cash flow

7.82 million USD

2018 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 20707000 USD Source
Operating Cash Flow: 12886000 USD Source

Free cash flow

5.7 million USD

2018 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 20707000 USD Source
Operating Cash Flow: 12886000 USD Source
Capital Expenditure: 4364000 USD Source
Capital Expenditure: 2241000 USD Source

Cash and cash equivalents: 81.9 million USD 2018-09-30 Source
Exact value

81944000 USD
Long-term debt including current maturities: 44.5 million USD 2011-12-31 Source
Exact value

44500000 USD
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-5.44 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Net income: -2269000 USD · 2017-10-01 – 2017-12-31 Source
Net income: -1459000 USD · 2018-01-01 – 2018-03-31 Source
Net income: -2589000 USD · 2018-04-01 – 2018-06-30 Source
Net income: 881000 USD · 2018-07-01 – 2018-09-30 Source

Operating cash flow

23.5 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Operating cash flow: 4802000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 1989000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -869000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 12886000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -869000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 20707000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: 12886000 USD · 2018-01-01 – 2018-06-30 Source

Capital expenditure

6.01 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Capital expenditure: 9194000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 7550000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 1092000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 2241000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 1092000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 4364000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 2241000 USD · 2018-01-01 – 2018-06-30 Source

Free cash flow

17.5 million USD

2017-10-01 – 2018-09-30

Exact inputs and evidence

Operating cash flow: 4802000 USD · 2017-01-01 – 2017-12-31 Source
Operating cash flow: 1989000 USD · 2017-01-01 – 2017-09-30 Source
Operating cash flow: -869000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 12886000 USD · 2018-01-01 – 2018-06-30 Source
Operating cash flow: -869000 USD · 2018-01-01 – 2018-03-31 Source
Operating cash flow: 20707000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: 12886000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 9194000 USD · 2017-01-01 – 2017-12-31 Source
Capital expenditure: 7550000 USD · 2017-01-01 – 2017-09-30 Source
Capital expenditure: 1092000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 2241000 USD · 2018-01-01 – 2018-06-30 Source
Capital expenditure: 1092000 USD · 2018-01-01 – 2018-03-31 Source
Capital expenditure: 4364000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 2241000 USD · 2018-01-01 – 2018-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-11-07.

Financial data available through: 2017-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2014-12-31
Operating income: 11 of 11 periods available· newest 2017-12-31
Net income: 11 of 11 periods available· newest 2017-12-31
Operating cash flow: 11 of 11 periods available· newest 2017-12-31
Capital expenditure: 11 of 11 periods available· newest 2017-12-31
Total assets: 11 of 11 periods available· newest 2017-12-31
Total liabilities: 11 of 11 periods available· newest 2017-12-31
Current assets: 11 of 11 periods available· newest 2017-12-31
Current liabilities: 11 of 11 periods available· newest 2017-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2017-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2011-12-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 9.22 million

Prior period

−USD 4.77 million

2016-01-01 – 2016-12-31
Current period

−USD 13.99 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

-13992000 − -4771000 = -9221000 USD

-4771000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
-13992000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Year-over-year change in Net income: -9221000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13992000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#322822 Filing: 000133317018000002 Input fundies:NetIncome: -4771000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#322057 Filing: 000133317018000002
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+4.7%

Prior period

USD 4.59 million

2016-01-01 – 2016-12-31
Current period

USD 4.8 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

4802000 − 4587000 = 215000 USD

4587000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
4802000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Year-over-year change in Operating cash flow: 215000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 4802000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#321082 Filing: 000133317018000002 Input fundies:OperatingCashFlow: 4587000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#320872 Filing: 000133317018000002
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+3.9%

Prior period

USD 8.85 million

2016-01-01 – 2016-12-31
Current period

USD 9.19 million

2017-01-01 – 2017-12-31

Exact inputs and evidence

9194000 − 8848000 = 346000 USD

8848000 USD · 2016-01-01 – 2016-12-31
Inspect prior input Prior source
9194000 USD · 2017-01-01 – 2017-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Year-over-year change in Capital expenditure: 346000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 9194000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357810 Filing: 000133317018000002 Input fundies:CapitalExpenditure: 8848000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357600 Filing: 000133317018000002
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 301.5 million 100% of revenue
Cost of revenue USD 185.6 million 62% of revenue
Operating expenses USD 138.09 million 46% of revenue
Operating income −USD 22.19 million −7.4% of revenue
Tax, interest and other Derived USD 1.76 million 0.6% of revenue
Net income −USD 23.95 million −7.9% of revenue

Cash

Operating cash flow −USD 20.27 million −6.7% of revenue
Capital expenditure USD 20.1 million 6.7% of revenue
Free cash flow Derived −USD 40.37 million −13% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Operating loss: operating costs were 139% of revenue.
2009 Operating loss: operating costs were 125% of revenue.
2010 Operating loss: operating costs were 115% of revenue.
2012 Operating loss: operating costs were 105% of revenue.
2013 Operating loss: operating costs were 107% of revenue.
2014 Operating loss: operating costs were 107% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	128763000	178748000 Derived	-49985000	1226000 Derived	-51211000	-56259000 Derived	Source 2008-01-01 – 2008-12-31: 128763000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -49985000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -51211000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -53222000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 3037000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	148676000	185123000 Derived	-36447000	7020000 Derived	-43467000	-14882000 Derived	Source 2009-01-01 – 2009-12-31: 148676000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -36447000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -43467000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -13157000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 1725000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	179218000	205682000 Derived	-26464000	5248000 Derived	-31712000	1555000 Derived	Source 2010-01-01 – 2010-12-31: 179218000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -26464000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -31712000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 3111000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 1556000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	242132000	253338000 Derived	-11206000	3947000 Derived	-15153000	-1453000 Derived	Source 2012-01-01 – 2012-12-31: 242132000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -11206000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -15153000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 6241000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 7694000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	263429000	281227000 Derived	-17798000	763000 Derived	-18561000	-26387000 Derived	Source 2013-01-01 – 2013-12-31: 263429000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -17798000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -18561000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -10141000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 16246000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	301501000	323688000 Derived	-22187000	1759000 Derived	-23946000	-40370000 Derived	Source 2014-01-01 – 2014-12-31: 301501000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -22187000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -23946000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -20273000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 20097000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 301.5M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Revenue	59964000	Revenue: 59964000 Open source
20082008-12-31	Revenue	128763000	Revenue: 128763000 Open source
20092009-12-31	Revenue	148676000	Revenue: 148676000 Open source
20102010-12-31	Revenue	179218000	Revenue: 179218000 Open source
20122012-12-31	Revenue	242132000	Revenue: 242132000 Open source
20132013-12-31	Revenue	263429000	Revenue: 263429000 Open source
20142014-12-31	Revenue	301501000	Revenue: 301501000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

14.5% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Year over year	No prior comparable period	Revenue: 59964000 Open source
20082008-12-31	Year over year	114.7%	Revenue: 128763000 Open source Revenue: 59964000 Open source
20092009-12-31	Year over year	15.5%	Revenue: 148676000 Open source Revenue: 128763000 Open source
20102010-12-31	Year over year	20.5%	Revenue: 179218000 Open source Revenue: 148676000 Open source
20122012-12-31	Year over year	No prior comparable period	Revenue: 242132000 Open source
20132013-12-31	Year over year	8.8%	Revenue: 263429000 Open source Revenue: 242132000 Open source
20142014-12-31	Year over year	14.5%	Revenue: 301501000 Open source Revenue: 263429000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7.4% 2014

Net margin -7.9% 2014

Free cash flow margin -13.4% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Operating margin	-100.2%	Operating Income: -60084000 Open source Revenue: 59964000 Open source
20082008-12-31	Operating margin	-38.8%	Operating Income: -49985000 Open source Revenue: 128763000 Open source
20092009-12-31	Operating margin	-24.5%	Operating Income: -36447000 Open source Revenue: 148676000 Open source
20102010-12-31	Operating margin	-14.8%	Operating Income: -26464000 Open source Revenue: 179218000 Open source
20122012-12-31	Operating margin	-4.6%	Operating Income: -11206000 Open source Revenue: 242132000 Open source
20132013-12-31	Operating margin	-6.8%	Operating Income: -17798000 Open source Revenue: 263429000 Open source
20142014-12-31	Operating margin	-7.4%	Operating Income: -22187000 Open source Revenue: 301501000 Open source
20072007-12-31	Net margin	-97.4%	Net Income: -58396000 Open source Revenue: 59964000 Open source
20082008-12-31	Net margin	-39.8%	Net Income: -51211000 Open source Revenue: 128763000 Open source
20092009-12-31	Net margin	-29.2%	Net Income: -43467000 Open source Revenue: 148676000 Open source
20102010-12-31	Net margin	-17.7%	Net Income: -31712000 Open source Revenue: 179218000 Open source
20122012-12-31	Net margin	-6.3%	Net Income: -15153000 Open source Revenue: 242132000 Open source
20132013-12-31	Net margin	-7%	Net Income: -18561000 Open source Revenue: 263429000 Open source
20142014-12-31	Net margin	-7.9%	Net Income: -23946000 Open source Revenue: 301501000 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 59964000 Open source
20082008-12-31	Free cash flow margin	-43.7%	Revenue: 128763000 Open source Operating Cash Flow: -53222000 Open source Capital Expenditure: 3037000 Open source
20092009-12-31	Free cash flow margin	-10%	Revenue: 148676000 Open source Operating Cash Flow: -13157000 Open source Capital Expenditure: 1725000 Open source
20102010-12-31	Free cash flow margin	0.9%	Revenue: 179218000 Open source Operating Cash Flow: 3111000 Open source Capital Expenditure: 1556000 Open source
20122012-12-31	Free cash flow margin	-0.6%	Revenue: 242132000 Open source Operating Cash Flow: 6241000 Open source Capital Expenditure: 7694000 Open source
20132013-12-31	Free cash flow margin	-10%	Revenue: 263429000 Open source Operating Cash Flow: -10141000 Open source Capital Expenditure: 16246000 Open source
20142014-12-31	Free cash flow margin	-13.4%	Revenue: 301501000 Open source Operating Cash Flow: -20273000 Open source Capital Expenditure: 20097000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -20.3M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	-53222000	Operating Cash Flow: -53222000 Open source
20092009-12-31	Operating cash flow	-13157000	Operating Cash Flow: -13157000 Open source
20102010-12-31	Operating cash flow	3111000	Operating Cash Flow: 3111000 Open source
20122012-12-31	Operating cash flow	6241000	Operating Cash Flow: 6241000 Open source
20132013-12-31	Operating cash flow	-10141000	Operating Cash Flow: -10141000 Open source
20142014-12-31	Operating cash flow	-20273000	Operating Cash Flow: -20273000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -40.4M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	-56259000	Operating Cash Flow: -53222000 Open source Capital Expenditure: 3037000 Open source
20092009-12-31	Free cash flow	-14882000	Operating Cash Flow: -13157000 Open source Capital Expenditure: 1725000 Open source
20102010-12-31	Free cash flow	1555000	Operating Cash Flow: 3111000 Open source Capital Expenditure: 1556000 Open source
20122012-12-31	Free cash flow	-1453000	Operating Cash Flow: 6241000 Open source Capital Expenditure: 7694000 Open source
20132013-12-31	Free cash flow	-26387000	Operating Cash Flow: -10141000 Open source Capital Expenditure: 16246000 Open source
20142014-12-31	Free cash flow	-40370000	Operating Cash Flow: -20273000 Open source Capital Expenditure: 20097000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

38.2% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Liabilities / assets	38.3%	Total Liabilities: 80669000 Open source Total Assets: 210386000 Open source
20082008-12-31	Liabilities / assets	42.3%	Total Liabilities: 89619000 Open source Total Assets: 212066000 Open source
20092009-12-31	Liabilities / assets	54.6%	Total Liabilities: 107532000 Open source Total Assets: 196978000 Open source
20102010-12-31	Liabilities / assets	46.8%	Total Liabilities: 133965000 Open source Total Assets: 286094000 Open source
20122012-12-31	Liabilities / assets	36.7%	Total Liabilities: 114358000 Open source Total Assets: 311949000 Open source
20132013-12-31	Liabilities / assets	36.6%	Total Liabilities: 112201000 Open source Total Assets: 306962000 Open source
20142014-12-31	Liabilities / assets	38.2%	Total Liabilities: 118171000 Open source Total Assets: 309726000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.89× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Current assets / current liabilities	2.18×	Current Assets: 75190000 Open source Current Liabilities: 34535000 Open source
20082008-12-31	Current assets / current liabilities	1.93×	Current Assets: 71401000 Open source Current Liabilities: 37039000 Open source
20092009-12-31	Current assets / current liabilities	2.23×	Current Assets: 65302000 Open source Current Liabilities: 29265000 Open source
20102010-12-31	Current assets / current liabilities	4.27×	Current Assets: 155480000 Open source Current Liabilities: 36391000 Open source
20122012-12-31	Current assets / current liabilities	4.12×	Current Assets: 161467000 Open source Current Liabilities: 39232000 Open source
20132013-12-31	Current assets / current liabilities	3.89×	Current Assets: 146120000 Open source Current Liabilities: 37607000 Open source
20142014-12-31	Current assets / current liabilities	2.89×	Current Assets: 129151000 Open source Current Liabilities: 44756000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 51.21 million Exact value Exact value: -51211000 USD 2008-01-01 – 2008-12-31: -51211000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2008-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -51211000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51211000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/0000950123-11-015749.txt#34788 The citation records this snapshot. The page link may show a newer release later.	−USD 53.22 million Exact value Exact value: -53222000 USD 2008-01-01 – 2008-12-31: -53222000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2008-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: -53222000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -53222000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/0000950123-11-015749.txt#35433 The citation records this snapshot. The page link may show a newer release later.	USD 3.04 million Exact value Exact value: 3037000 USD 2008-01-01 – 2008-12-31: 3037000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2008-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 3037000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3037000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/0000950123-11-015749.txt#35560 The citation records this snapshot. The page link may show a newer release later.	−USD 56.26 million Calculation and evidence -53222000 − 3037000 USD Exact free cash flow: -56259000 USD 2008-01-01 – 2008-12-31: -53222000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 3037000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2008-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -56259000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -53222000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/0000950123-11-015749.txt#35433 Input fundies:CapitalExpenditure: 3037000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/0000950123-11-015749.txt#35560 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 43.47 million Exact value Exact value: -43467000 USD 2009-01-01 – 2009-12-31: -43467000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2009-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -43467000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43467000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312512087622/nxtm-20111231.xml#937778 Filing: 000119312512087622 The citation records this snapshot. The page link may show a newer release later.	−USD 13.16 million Exact value Exact value: -13157000 USD 2009-01-01 – 2009-12-31: -13157000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2009-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: -13157000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13157000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312512087622/nxtm-20111231.xml#937227 Filing: 000119312512087622 The citation records this snapshot. The page link may show a newer release later.	USD 1.73 million Exact value Exact value: 1725000 USD 2009-01-01 – 2009-12-31: 1725000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2009-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 1725000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1725000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312512087622/nxtm-20111231.xml#952004 Filing: 000119312512087622 The citation records this snapshot. The page link may show a newer release later.	−USD 14.88 million Calculation and evidence -13157000 − 1725000 USD Exact free cash flow: -14882000 USD 2009-01-01 – 2009-12-31: -13157000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 1725000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2009-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -14882000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13157000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312512087622/nxtm-20111231.xml#937227 Filing: 000119312512087622 Input fundies:CapitalExpenditure: 1725000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312512087622/nxtm-20111231.xml#952004 Filing: 000119312512087622 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 31.71 million Exact value Exact value: -31712000 USD 2010-01-01 – 2010-12-31: -31712000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2010-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -31712000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31712000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312513084320/nxtm-20121231.xml#1172330 Filing: 000119312513084320 The citation records this snapshot. The page link may show a newer release later.	USD 3.11 million Exact value Exact value: 3111000 USD 2010-01-01 – 2010-12-31: 3111000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2010-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: 3111000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3111000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312513084320/nxtm-20121231.xml#1171781 Filing: 000119312513084320 The citation records this snapshot. The page link may show a newer release later.	USD 1.56 million Exact value Exact value: 1556000 USD 2010-01-01 – 2010-12-31: 1556000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2010-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 1556000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1556000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312513084320/nxtm-20121231.xml#1187253 Filing: 000119312513084320 The citation records this snapshot. The page link may show a newer release later.	USD 1.56 million Calculation and evidence 3111000 − 1556000 USD Exact free cash flow: 1555000 USD 2010-01-01 – 2010-12-31: 3111000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 1556000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2010-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: 1555000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3111000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312513084320/nxtm-20121231.xml#1171781 Filing: 000119312513084320 Input fundies:CapitalExpenditure: 1556000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312513084320/nxtm-20121231.xml#1187253 Filing: 000119312513084320 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 21.4 million Exact value Exact value: -21402000 USD 2011-01-01 – 2011-12-31: -21402000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2011-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -21402000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21402000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312514080178/nxtm-20131231.xml#107597 Filing: 000119312514080178 The citation records this snapshot. The page link may show a newer release later.	−USD 1.52 million Exact value Exact value: -1516000 USD 2011-01-01 – 2011-12-31: -1516000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2011-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: -1516000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1516000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312514080178/nxtm-20131231.xml#98478 Filing: 000119312514080178 The citation records this snapshot. The page link may show a newer release later.	USD 5.16 million Exact value Exact value: 5156000 USD 2011-01-01 – 2011-12-31: 5156000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2011-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 5156000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5156000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312514080178/nxtm-20131231.xml#109529 Filing: 000119312514080178 The citation records this snapshot. The page link may show a newer release later.	−USD 6.67 million Calculation and evidence -1516000 − 5156000 USD Exact free cash flow: -6672000 USD 2011-01-01 – 2011-12-31: -1516000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 5156000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2011-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -6672000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1516000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312514080178/nxtm-20131231.xml#98478 Filing: 000119312514080178 Input fundies:CapitalExpenditure: 5156000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312514080178/nxtm-20131231.xml#109529 Filing: 000119312514080178 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 15.15 million Exact value Exact value: -15153000 USD 2012-01-01 – 2012-12-31: -15153000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2012-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -15153000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15153000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312515064412/nxtm-20141231.xml#1503681 Filing: 000119312515064412 The citation records this snapshot. The page link may show a newer release later.	USD 6.24 million Exact value Exact value: 6241000 USD 2012-01-01 – 2012-12-31: 6241000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2012-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: 6241000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6241000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312515064412/nxtm-20141231.xml#1492812 Filing: 000119312515064412 The citation records this snapshot. The page link may show a newer release later.	USD 7.69 million Exact value Exact value: 7694000 USD 2012-01-01 – 2012-12-31: 7694000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2012-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 7694000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7694000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312515064412/nxtm-20141231.xml#1503183 Filing: 000119312515064412 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Calculation and evidence 6241000 − 7694000 USD Exact free cash flow: -1453000 USD 2012-01-01 – 2012-12-31: 6241000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 7694000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2012-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -1453000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6241000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312515064412/nxtm-20141231.xml#1492812 Filing: 000119312515064412 Input fundies:CapitalExpenditure: 7694000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000119312515064412/nxtm-20141231.xml#1503183 Filing: 000119312515064412 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 18.56 million Exact value Exact value: -18561000 USD 2013-01-01 – 2013-12-31: -18561000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2013-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -18561000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18561000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317016000025/nxtm-20151231.xml#320295 Filing: 000133317016000025 The citation records this snapshot. The page link may show a newer release later.	−USD 10.14 million Exact value Exact value: -10141000 USD 2013-01-01 – 2013-12-31: -10141000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2013-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: -10141000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10141000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317016000025/nxtm-20151231.xml#319540 Filing: 000133317016000025 The citation records this snapshot. The page link may show a newer release later.	USD 16.25 million Exact value Exact value: 16246000 USD 2013-01-01 – 2013-12-31: 16246000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2013-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 16246000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16246000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317016000025/nxtm-20151231.xml#349182 Filing: 000133317016000025 The citation records this snapshot. The page link may show a newer release later.	−USD 26.39 million Calculation and evidence -10141000 − 16246000 USD Exact free cash flow: -26387000 USD 2013-01-01 – 2013-12-31: -10141000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 16246000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2013-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -26387000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10141000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317016000025/nxtm-20151231.xml#319540 Filing: 000133317016000025 Input fundies:CapitalExpenditure: 16246000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317016000025/nxtm-20151231.xml#349182 Filing: 000133317016000025 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 23.95 million Exact value Exact value: -23946000 USD 2014-01-01 – 2014-12-31: -23946000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2014-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -23946000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23946000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317017000005/nxtm-20161231.xml#305174 Filing: 000133317017000005 The citation records this snapshot. The page link may show a newer release later.	−USD 20.27 million Exact value Exact value: -20273000 USD 2014-01-01 – 2014-12-31: -20273000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2014-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: -20273000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20273000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317017000005/nxtm-20161231.xml#304541 Filing: 000133317017000005 The citation records this snapshot. The page link may show a newer release later.	USD 20.1 million Exact value Exact value: 20097000 USD 2014-01-01 – 2014-12-31: 20097000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2014-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 20097000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20097000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317017000005/nxtm-20161231.xml#336730 Filing: 000133317017000005 The citation records this snapshot. The page link may show a newer release later.	−USD 40.37 million Calculation and evidence -20273000 − 20097000 USD Exact free cash flow: -40370000 USD 2014-01-01 – 2014-12-31: -20273000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 20097000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2014-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -40370000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20273000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317017000005/nxtm-20161231.xml#304541 Filing: 000133317017000005 Input fundies:CapitalExpenditure: 20097000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317017000005/nxtm-20161231.xml#336730 Filing: 000133317017000005 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 15.34 million Exact value Exact value: -15342000 USD 2015-01-01 – 2015-12-31: -15342000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2015-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -15342000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15342000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#321292 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 10.54 million Exact value Exact value: 10542000 USD 2015-01-01 – 2015-12-31: 10542000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2015-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: 10542000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 10542000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#320661 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 11.54 million Exact value Exact value: 11537000 USD 2015-01-01 – 2015-12-31: 11537000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2015-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 11537000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11537000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357389 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	−USD 995,000 Calculation and evidence 10542000 − 11537000 USD Exact free cash flow: -995000 USD 2015-01-01 – 2015-12-31: 10542000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 11537000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2015-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -995000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 10542000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#320661 Filing: 000133317018000002 Input fundies:CapitalExpenditure: 11537000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357389 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 4.77 million Exact value Exact value: -4771000 USD 2016-01-01 – 2016-12-31: -4771000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2016-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -4771000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4771000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#322057 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 4.59 million Exact value Exact value: 4587000 USD 2016-01-01 – 2016-12-31: 4587000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2016-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: 4587000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4587000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#320872 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 8.85 million Exact value Exact value: 8848000 USD 2016-01-01 – 2016-12-31: 8848000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2016-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 8848000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8848000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357600 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	−USD 4.26 million Calculation and evidence 4587000 − 8848000 USD Exact free cash flow: -4261000 USD 2016-01-01 – 2016-12-31: 4587000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 8848000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2016-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -4261000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4587000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#320872 Filing: 000133317018000002 Input fundies:CapitalExpenditure: 8848000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357600 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 13.99 million Exact value Exact value: -13992000 USD 2017-01-01 – 2017-12-31: -13992000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Net Income: -13992000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13992000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#322822 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 4.8 million Exact value Exact value: 4802000 USD 2017-01-01 – 2017-12-31: 4802000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Operating Cash Flow: 4802000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4802000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#321082 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	USD 9.19 million Exact value Exact value: 9194000 USD 2017-01-01 – 2017-12-31: 9194000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Capital Expenditure: 9194000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9194000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357810 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.	−USD 4.39 million Calculation and evidence 4802000 − 9194000 USD Exact free cash flow: -4392000 USD 2017-01-01 – 2017-12-31: 4802000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 9194000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NxStage Medical, Inc. · 2017-12-31 NxStage Medical, Inc. (edgar:1333170) Free cash flow: -4392000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:20:23Z Snapshot: 70d294c8dc6bc9c9323a6e0262ff294a54d739d100402efeff018680d3a2130d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333170?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4802000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#321082 Filing: 000133317018000002 Input fundies:CapitalExpenditure: 9194000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1333170/000133317018000002/nxtm-20171231.xml#357810 Filing: 000133317018000002 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

177 filings · 2,832 latest values · 2,832 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001333170, 1333170, NXTM, edgar:1333170

Also known as NxStage Medical, Inc.

NxStage Medical, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation